View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Centocor Inc

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market

2009 NOV 9 ... Keywords: Adalimumab, Amgen Inc., Biotechnology Business, Biotechnology Company, Centocor Inc., Dermatology, Drugs, Enbrel, Etanercept, Humira, Ortho Biotech, Pfizer, Pharmaceutical ...

Subject: Psoriasis

Price: $3.00

First-Ever Maryland Psoriasis Walk Tomorrow, October 17

2009 NOV 1 ... occur in Charlotte, NC. Sponsors of the Baltimore Psoriasis Walk include Centocor Ortho Biotech, Abbott, Amgen & Wyeth, and Parexel. Psoriasis is an incurable, recurring ...

Subject: Psoriatic Arthritis

Price: $3.00

First-Ever North Carolina Psoriasis Walk This Saturday in Charlotte

2009 NOV 2 ... are welcome. Sponsors of the Charlotte Psoriasis Walk include Abbott, Centocor Ortho Biotech, and Amgen & Wyeth. Psoriasis is an incurable, recurring disease of the ...

Subject: Psoriatic Arthritis

Price: $3.00

First-ever Philadelphia Psoriasis Walk Coming This Sunday, October 4

2009 OCT 12 ... Sponsors of the Philadelphia Psoriasis Walk include Amgen & Wyeth, Centocor Ortho Biotech, Abbott, Goapharma, and the Psoriasis Treatment Center of Central NJ. ...

Subject: Psoriasis

Price: $3.00

Five Prime Therapeutics, Inc. Adds Key Leaders to Its Management Team

2009 NOV 1 ... I with FP-1039 for solid tumors. Pharmaceutical partners include Johnson & Johnson's Centocor division and Pfizer, Inc. For more information, visit www.fiveprime.com. ...

Subject: Five Prime Therapeutics, Inc.

Price: $3.00

Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody

2009 NOV 9 ... Keywords: Biotechnology, Biotechnology Business, Biotechnology Company, Centocor Inc., Clinical Trial Research, Clinical Trials, Marketing and Licensing Agreements, Medical ...

Subject: Biotechnology Business

Price: $3.00

Morphotek, Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody

2009 NOV 9 ... Investing, Investment, Biotechnology, Biotechnology Business, Biotechnology Company, Centocor Inc., Clinical Trial Research, Clinical Trials, Medical Device, Monoclonal Antibody, ...

Subject: Morphotek, Inc.

Price: $3.00

New monoclonal antibodies data have been reported by R.J. Brezski and co-authors

2009 NOV 16 ... For additional information, contact R.J. Brezski, Centocor R&D Inc., Biology Research, Radnor, PA 19087, USA. Publisher contact ...

Subject: Monoclonal Antibodies

Price: $3.00

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

2009 NOV 2 ... Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatology, Therapy, Treatment, Centocor Ortho Biotech Inc. This article was prepared by Pain & Central Nervous ...

Subject: Psoriatic Arthritis

Price: $3.00

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

2009 NOV 2 ... Arthritis, Rheumatology, Therapy, Treatment, U.S. Food and Drug Administration, Centocor Ortho Biotech Inc. This article was prepared by Pain & Central Nervous ...

Subject: Arthritis

Price: $3.00

Photos: STELARA(TM) (ustekinumab) Receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing

2009 OCT 12 ... Keywords: Biotechnology, Biotechnology Business, Biotechnology Company, Centocor Inc., Clinical Trial Research, Cytokines, Dermatology, Drug Development, FDA, Medical ...

Subject: Psoriasis

Price: $3.00

Prescribing Options for Treating Inflammation Positioned to Benefit from an Active Drug Pipeline

2009 NOV 16 ... recently became more competitive with the FDA approvals of two more TNF antagonists - Centocor's Simponi in April and UCB's Cimzia in May. With more than a dozen additional drug ... Source: Greystone Associates Keywords: Aging, Amgen Inc., Biotechnology, Cimzia, Drug Development, Drugs, Enzymes, FDA, Inflammation, Kinase, ...

Subject: Inflammation

Price: $3.00

Special Report: Can Innovation Supplant Convention in Sarcoidosis Treatment?

2009 NOV 2 ... Emerging treatments: Celgene's apremilast, MondoBiotech/Biogen Idec's aviptadil, Centocor/Medarex's Stelara, ongoing academic research. Market: 2008 sales, ... has announced the addition of Decision Resources, Inc.'s new report "Special Report: Can Innovation Supplant Convention in Sarcoidosis ...

Subject: Research and Markets

Price: $3.00

Stelara is Expected to Substantially Alter Patient Flow to TNF-Alpha Inhibitors Prescribed for Psoriasis Over the Next Two Years

2009 NOV 23 ... Keywords: Adalimumab, Amgen Inc., Biotechnology Business, Biotechnology Company, Centocor Inc., Corticosteroid, Dermatology, Drugs, Enbrel, Etanercept, Humira, Ortho Biotech, ...

Subject: Psoriasis

Price: $3.00

Studies from R.M. Attar and co-researchers in the area of prostate cancer published

2009 OCT 5 ... 2009;69(16):6522-6530). For additional information, contact R.M. Attar, Centocor R&D Inc., Oncology Research, 145 King Prussia Rd., R-4-2, Radnor, PA 19087, USA. ...

Subject: Prostate Cancer

Price: $3.00

TNF-Alpha Inhibitors Will Continue to Dominate First- and Second-Line Biologic Therapy for the Treatment of Rheumatoid Arthritis Through 2011

2009 NOV 2 ... Adalimumab, Amgen Inc., Arthritis, Biotechnology Business, Biotechnology Company, Centocor Inc., Cimzia, Drugs, Enbrel, Etanercept, Humira, Infliximab, Necrosis, Ortho Biotech, ...

Subject: Arthritis

Price: $3.00

Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half

2009 OCT 12 ... rankings began 20 years ago. Dr. Sandborn provided consulting services for Centocor during the course of this research and received no personal compensation. Mayo Clinic ...

Subject: Monoclonal Antibodies

Price: $3.00

Unifying Practice Patterns Among Academic and Community Clinicians: Focus on Myeloma

2009 NOV 9 ... Supported by an educational grant from Millennium Pharmaceuticals, Inc., Centocor Ortho Biotech Services, LLC, Ortho Biotech, a division of Janssen Cilag, and Genzyme ...

Subject: Myeloma

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx